Clear Creek Financial Management’s Novo Nordisk NVO Stock Holding History

Clear Creek Financial Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Sell	28,506 -2,075	-7%	-$89.2K	0.09%	231
2026 Q1	$1.12M	Buy	30,581 +14,443	+89%	+$684K	0.09%	237
2025 Q4	$821K	Buy	+16,138	New	+$825K	0.07%	274
2025 Q1	–	Sell	-5,234	Closed	-$450K	–	539
2024 Q4	$450K	Buy	+5,234	New	+$566K	0.05%	313

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Clear Creek Financial Management's NVO Position: Q2 2026 in Review

Clear Creek Financial Management reduced its Novo Nordisk (NVO) stake by 6.8% in Q2 2026, selling an estimated $89.2K and leaving 28,506 shares worth $1.37M. The position accounts for 0.09% of the portfolio, ranked #231.

Clear Creek Financial Management first reported a position in NVO in Q4 2024 and has held it in 4 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Clear Creek Financial Management held 28,506 shares of Novo Nordisk worth $1.37M as of Q2 2026.
Clear Creek Financial Management sold 2,075 Novo Nordisk shares in Q2 2026, an estimated $89.2K.
Novo Nordisk made up 0.09% of Clear Creek Financial Management's portfolio in Q2 2026, its #231 holding.
Clear Creek Financial Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 4 quarters since.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Clear Creek Financial Management's 13F filing for Q2 2026, filed 28 Jul 2026.